详细信息
特异性
This product detects an epitope near the C-terminus of the FOXP3 protein and is expected to detect full length FOXP3. It is not expected to detect the cleaved forms of FOXP3.
背景信息
Want a custom formulation? This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
文献引用 (74)
Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses
人工智能将 CT 图像与肾肿块的病理特征和生存结果联系起来
Grape seed extract and L-ascorbic acid exert antineoplastic effects against solid Ehrlich carcinoma in vivo by modulating the tumor microenvironment and Th1/Th2 balance.
葡萄籽提取物和 L-抗坏血酸通过调节肿瘤微环境和 Th1/Th2 平衡，在体内对实体 Ehrlich 癌发挥抗肿瘤作用
Immunohistochemical analysis of p53 and LKB1 as predictive biomarkers of immune checkpoint inhibitor response in non-small cell lung cancer.
对 p53 和 LKB1 作为非小细胞肺癌免疫检查点抑制剂反应的预测生物标志物的免疫组织化学分析。
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104)
新辅助信迪利单抗联合化疗治疗 EGFR 突变型非小细胞肺癌：2 期试验中期结果 (NEOTIDE/CTONG2104)
Co-transplantation of autologous Treg cells in a cell therapy for Parkinson's disease
在帕金森病细胞疗法中，自体Treg细胞与原体Treg细胞共同移植
Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing
多组学测序追踪动态免疫选择下食管鳞状细胞癌的演变
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells
低剂量放射疗法联合PD-L1和VEGFA双重阻断可诱导肝细胞癌产生抗肿瘤反应，该反应由活化的肿瘤内CD8+耗竭样T细胞介导。
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer
补铁可增强 RSL3 诱导的铁死亡，从而治疗幼稚前列腺癌并预防去势抵抗性前列腺癌
Prognostic impact of intra- and peritumoral immune cell subpopulations in head and neck squamous cell carcinomas - comprehensive analysis of the TCGA-HNSC cohort and immunohistochemical validation on 101 patients
头颈部鳞状细胞癌中肿瘤内和肿瘤周围免疫细胞亚群的预后影响 - 对 TCGA-HNSC 队列的全面分析和对 101 名患者的免疫组织化学验证
The oesophageal adenocarcinoma tumour immune microenvironment dictates outcomes with different modalities of neoadjuvant therapy - results from the AGITG DOCTOR trial and the cancer evolution biobank
食管腺癌肿瘤免疫微环境决定了不同新辅助治疗方式的结果 - 来自 AGITG DOCTOR 试验和癌症进化生物库的结果
- 1
- 2
- 3
- 4
- 5
- 6
- 8